Needham cuts Clarivate stock price target on valuation pullback
#Needham #Clarivate Analytics #Price Target #Stock Rating #Valuation #NASDAQ #Investment Firm
📌 Key Takeaways
- Needham reduced Clarivate's price target from $11.00 to $9.00
- Needham maintained a Buy rating on Clarivate stock
- Clarivate shares trade at $5.06, near 52-week low of $4.80
- Potential upside of nearly 80% to Needham's new target
- The adjustment was due to valuation pullback
📖 Full Retelling
Needham, an investment firm, has reduced its price target for Clarivate Analytics (NASDAQ:CCC) stock to $9.00 from $11.00 while maintaining a Buy rating, citing valuation pullback as the reason for the adjustment. The shares currently trade at $5.06, near their 52-week low of $4.80, indicating potential upside of nearly 80% according to Needham's revised target. The adjustment reflects changing market conditions and valuation expectations for the analytics and information services provider. Despite the lowered price target, Needham's continued Buy rating suggests confidence in Clarivate's long-term fundamentals and growth prospects amid current market challenges. The significant gap between current trading price and the revised target indicates that analysts still see substantial value in the company despite recent market pressures.
🏷️ Themes
Stock Market, Investment Analysis, Financial Adjustments
📚 Related People & Topics
Clarivate
American analytics company
Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance;...
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
Investing.com - Needham lowered its price target on Clarivate Analytics (NASDAQ:CCC) shares to $9.00 from $11.00 while maintaining a Buy rating on the stock. The shares currently trade at $5.06, near their 52-week low of $4.80, suggesting potential upside of nearly 80% to Needham’s target.
Read full article at source